US$ 27.25
glp 1 agonist vs ozempic GLP-1 receptor agonists Is GLP-1 the Same as
Description
Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W (1993) Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

doi: 10.1016/j.bbrc.2018.02.126

Because obesity is a chronic disease, many patients end up discovering that GLP-1 treatment is not really a short-term intervention
95% CI, 0.89-2.53)

Mounjaro activates both pathways, creating a dual-hormone effect for patients
